Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
13F holders, Q4 2024
Institutional positions in Gyre Therapeutics, Inc. as of Dec 31, 2024. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 41
- +4 vs. Q3 2024
- Shares held
- 1.79M
- +177.0K (+11.0%) vs. Q3 2024
- Total value
- $21.6M
- +$1.43M (+7.1%) vs. Q3 2024
- New holders
- 6
- 17 more added
- Sold out
- 2
- 11 more reduced
Compare with Q3 2024: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting GYRE on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 59 | $57.1M |
| Q1 2026 | 56 | $23.8M |
| Q4 2025 | 44 | $23.6M |
| Q3 2025 | 48 | $23.1M |
| Q2 2025 | 48 | $25.1M |
| Q1 2025 | 46 | $20.1M |
| Q4 2024 | 41 | $21.6M |
| Q3 2024 | 37 | $20.2M |
| Q2 2024 | 30 | $15.0M |
| Q1 2024 | 21 | $14.3M |
| Q4 2023 | 16 | $15.6M |
| Q3 2023 | 32 | $1.04M |
| Q2 2023 | 29 | $796.3K |
| Q1 2023 | 40 | $707.6K |
| Q4 2022 | 35 | $2.63M |
| Q3 2022 | 35 | $3.90M |
| Q2 2022 | 41 | $14.2M |
| Q1 2022 | 43 | $6.39M |
| Q4 2021 | 51 | $13.7M |
| Q3 2021 | 66 | $75.7M |
| Q2 2021 | 69 | $87.7M |
| Q1 2021 | 89 | $113.0M |
Institutions, Q4 2024
Shares, value and share of portfolio for each institution holding Gyre Therapeutics, Inc.; share changes are against Q3 2024.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| CWM, LLC | 15 | $0 | 0.00% | −15−50.0% | Reduced |
| Covestor Ltd | 7 | $0 | 0.00% | +1+16.7% | Added |
| IFP Advisors, Inc | 2 | $24 | 0.00% | +2 | New |
| GAMMA Investing LLC | 12 | $145 | 0.00% | +12 | New |
| Parallel Advisors, LLC | 15 | $182 | 0.00% | +15 | New |
| Advisor Group Holdings, Inc. | 41 | $496 | 0.00% | −400−90.7% | Reduced |
| Federation des caisses Desjardins du Quebec | 75 | $908 | 0.00% | +75 | New |
| Nisa Investment Advisors, LLC | 84 | $1.02K | 0.00% | 00.0% | Unchanged |
| Sterling Capital Management LLC | 216 | $2.61K | 0.00% | +195+928.6% | Added |
| Amalgamated Bank | 241 | $3.00K | 0.00% | 00.0% | Unchanged |
| California State Teachers Retirement System | 505 | $6.11K | 0.00% | 00.0% | Unchanged |
| Activest Wealth Management | 533 | $6.45K | 0.00% | 00.0% | Unchanged |
| Legal & General Group Plc | 603 | $7.29K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 683 | $8.26K | 0.00% | 00.0% | Unchanged |
| Royal Bank of Canada | 810 | $10.0K | 0.00% | −154−16.0% | Reduced |
| Tower Research Capital LLC (TRC) | 852 | $10.3K | 0.00% | −6−0.7% | Reduced |
| Picton Mahoney Asset Management | 1,120 | $14.0K | 0.00% | +1,120 | New |
| FMR LLC | 1,256 | $15.2K | 0.00% | −2,486−66.4% | Reduced |
| BNP Paribas Arbitrage, SA | 1,394 | $16.9K | 0.00% | −553−28.4% | Reduced |
| Belvedere Trading LLC | 2,461 | $29.8K | 0.00% | −54−2.1% | Reduced |
| New York State Common Retirement Fund | 2,700 | $32.7K | 0.00% | 00.0% | Unchanged |
| JPMorgan Chase & Co | 3,269 | $39.6K | 0.00% | +237+7.8% | Added |
| Corebridge Financial, Inc. | 3,468 | $42.0K | 0.00% | −262−7.0% | Reduced |
| Mirae Asset Global ETFs Holdings Ltd. | 4,013 | $48.6K | 0.00% | +152+3.9% | Added |
| Wells Fargo & Company | 4,016 | $48.6K | 0.00% | +913+29.4% | Added |
| Citigroup Inc | 5,399 | $65.3K | 0.00% | +323+6.4% | Added |
| Bank of America Corp | 6,937 | $83.9K | 0.00% | +1,996+40.4% | Added |
| Advantage Alpha Capital Partners LP | 8,873 | $107.4K | 0.03% | −17,761−66.7% | Reduced |
| Rhumbline Advisers | 10,432 | $126.2K | 0.00% | +8+0.1% | Added |
| Barclays PLC | 10,543 | $127.6K | 0.00% | +1,255+13.5% | Added |
| Bank of New York Mellon Corp | 13,896 | $168.1K | 0.00% | +1,389+11.1% | Added |
| Morgan Stanley | 15,241 | $184.4K | 0.00% | −2,981−16.4% | Reduced |
| Goldman Sachs Group Inc | 26,386 | $319.3K | 0.00% | +7,587+40.4% | Added |
| UBS Group AG | 57,084 | $690.7K | 0.00% | +53,441+1,467.0% | Added |
| SBI Securities Co., Ltd. | 101,239 | $1.22M | 0.04% | +101,239 | New |
| Northern Trust Corp | 103,382 | $1.25M | 0.00% | +8,624+9.1% | Added |
| Charles Schwab Investment Management Inc | 114,566 | $1.39M | 0.00% | +918+0.8% | Added |
| State Street Corp | 126,647 | $1.53M | 0.00% | +22,157+21.2% | Added |
| Geode Capital Management, LLC | 304,098 | $3.68M | 0.00% | +451+0.1% | Added |
| Vanguard Group Inc | 322,464 | $3.90M | 0.00% | −17,707−5.2% | Reduced |
| BlackRock, Inc. | 531,680 | $6.43M | 0.00% | +17,259+3.4% | Added |
| Capital Performance Advisors LLP | 0 | $0 | 0.00% | −6−100.0% | Sold out |
| Danske Bank A/S | 0 | $0 | 0.00% | −1−100.0% | Sold out |